BACKGROUND: Macrophage (MΦ) infiltration and smooth muscle cell (SMC) proliferation are hallmarks of atherosclerosis and unstable plaques. Neuroimmune guidance cue 1 (netrin-1 [NTN1]) plays a critical role controlling MΦ trafficking and SMC activation. Characterization of expression of NTN1 and its receptors and their association with plaque stability in human(s) is lacking. METHODS AND RESULTS: The expression of NTN1 and its receptors did not differ in either whole blood or circulating monocytes from patients with coronary artery disease (n=55) compared with healthy controls (n=45). However, NTN1 was downregulated (-2.9-fold; P<0.0001) and UNC5B upregulated (2.2-fold; P<0.0001) in atherosclerotic plaques (n=68), whereas there were no differences in other NTN1 receptors compared with histologically normal controls (n=28). Increased UNC5B expression is associated with histologically more stable plaques (P=0.011). NTN1 expression correlated positively with SMC markers and signatures and negatively with inflammatory markers and M1 and especially M2 signatures in the atherosclerotic plaques. UNC5B clustering correlated positively with inflammatory and MΦ markers. NTN1 protein colocalized with CD68-positive cells of monocytic origin and muscle-actin-specific-antibody (HHF3)-positive cells indicative of SMCs in the plaques and only with SMCs in the control samples. NTN1 protein was highly expressed in the intimal layer of the control vessels. CONCLUSIONS: Present findings provide support for the hypothesis that dysregulation of expression of NTN1 in SMCs and its chemorepulsive receptor UNC5B in macrophages are involved in the development of atherosclerosis and unstable plaques.
BACKGROUND: Macrophage (MΦ) infiltration and smooth muscle cell (SMC) proliferation are hallmarks of atherosclerosis and unstable plaques. Neuroimmune guidance cue 1 (netrin-1 [NTN1]) plays a critical role controlling MΦ trafficking and SMC activation. Characterization of expression of NTN1 and its receptors and their association with plaque stability in human(s) is lacking. METHODS AND RESULTS: The expression of NTN1 and its receptors did not differ in either whole blood or circulating monocytes from patients with coronary artery disease (n=55) compared with healthy controls (n=45). However, NTN1 was downregulated (-2.9-fold; P<0.0001) and UNC5B upregulated (2.2-fold; P<0.0001) in atherosclerotic plaques (n=68), whereas there were no differences in other NTN1 receptors compared with histologically normal controls (n=28). Increased UNC5B expression is associated with histologically more stable plaques (P=0.011). NTN1 expression correlated positively with SMC markers and signatures and negatively with inflammatory markers and M1 and especially M2 signatures in the atherosclerotic plaques. UNC5B clustering correlated positively with inflammatory and MΦ markers. NTN1 protein colocalized with CD68-positive cells of monocytic origin and muscle-actin-specific-antibody (HHF3)-positive cells indicative of SMCs in the plaques and only with SMCs in the control samples. NTN1 protein was highly expressed in the intimal layer of the control vessels. CONCLUSIONS: Present findings provide support for the hypothesis that dysregulation of expression of NTN1 in SMCs and its chemorepulsive receptor UNC5B in macrophages are involved in the development of atherosclerosis and unstable plaques.
Authors: Hannu Turpeinen; Ilkka Seppälä; Leo-Pekka Lyytikäinen; Emma Raitoharju; Nina Hutri-Kähönen; Mari Levula; Niku Oksala; Melanie Waldenberger; Norman Klopp; Thomas Illig; Nina Mononen; Reijo Laaksonen; Olli Raitakari; Mika Kähönen; Terho Lehtimäki; Marko Pesu Journal: Hum Genet Date: 2015-03-27 Impact factor: 4.132
Authors: Xue Fei Han; Yuan Zhang; Liu Lin Xiong; Yang Xu; Piao Zhang; Qing Jie Xia; Ting Hua Wang; Ying Chun Ba Journal: Mol Neurobiol Date: 2016-02-12 Impact factor: 5.590
Authors: Sujoy Ghosh; Juan Vivar; Christopher P Nelson; Christina Willenborg; Ayellet V Segrè; Ville-Petteri Mäkinen; Majid Nikpay; Jeannette Erdmann; Stefan Blankenberg; Christopher O'Donnell; Winfried März; Reijo Laaksonen; Alexandre F R Stewart; Stephen E Epstein; Svati H Shah; Christopher B Granger; Stanley L Hazen; Sekar Kathiresan; Muredach P Reilly; Xia Yang; Thomas Quertermous; Nilesh J Samani; Heribert Schunkert; Themistocles L Assimes; Ruth McPherson Journal: Arterioscler Thromb Vasc Biol Date: 2015-05-14 Impact factor: 8.311
Authors: Dimitry A Chistiakov; Andrey V Grechko; Veronika A Myasoedova; Alexandra A Melnichenko; Alexander N Orekhov Journal: J Cell Mol Med Date: 2018-01-24 Impact factor: 5.310
Authors: Martin Schlegel; Monika Sharma; Emily J Brown; Alexandra A C Newman; Yannick Cyr; Milessa Silva Afonso; Emma M Corr; Graeme J Koelwyn; Coen van Solingen; Jonathan Guzman; Rubab Farhat; Cyrus A Nikain; Lianne C Shanley; Daniel Peled; Ann Marie Schmidt; Edward A Fisher; Kathryn J Moore Journal: Circ Res Date: 2021-07-22 Impact factor: 23.213
Authors: Matthew Traylor; Kari-Matti Mäkelä; Laura L Kilarski; Elizabeth G Holliday; William J Devan; Mike A Nalls; Kerri L Wiggins; Wei Zhao; Yu-Ching Cheng; Sefanja Achterberg; Rainer Malik; Cathie Sudlow; Steve Bevan; Emma Raitoharju; Niku Oksala; Vincent Thijs; Robin Lemmens; Arne Lindgren; Agnieszka Slowik; Jane M Maguire; Matthew Walters; Ale Algra; Pankaj Sharma; John R Attia; Giorgio B Boncoraglio; Peter M Rothwell; Paul I W de Bakker; Joshua C Bis; Danish Saleheen; Steven J Kittner; Braxton D Mitchell; Jonathan Rosand; James F Meschia; Christopher Levi; Martin Dichgans; Terho Lehtimäki; Cathryn M Lewis; Hugh S Markus Journal: PLoS Genet Date: 2014-07-31 Impact factor: 5.917